Alpha-synuclein inhibitors are a class of investigational therapies targeting the pathological aggregation of alpha-synuclein, a protein implicated i ...

AI predicts Parkinson’s disease using medical and prescription data, enhancing early diagnosis and research into new ...

21, 2025 — The B vitamin mitigates manganese neurotoxicity, which produces symptoms that resemble ... Detecting Movement Defects in Early Stage Parkinson's Disease Aug. 15, 2024 — Using ...

A new study published in the Journal of Medical Internet Research has found that regular participation in dance classes can ...

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...

The class’ availability online through Zoom is a major feature. With how Parkinson’s can affect movement, and the ability to travel not always guaranteed, having access to pivotal information ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...

Now, a new study from Renmin Hospital of Wuhan University provides strong evidence that kidney failure may also contribute to the development of Parkinson’s disease by triggering the spread of ...

The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...

COPD is a progressive lung disease with mild symptoms in the early stages that gradually worsen. Early diagnosis and treatment can help preserve lung function. People with COPD often have trouble ...